GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Glucose Health, Inc.
Financials through Q3 FY2017, quarter ended Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)
Close on Oct 19, 2026
- Market cap
- $1.82M
- P/E (TTM)
- –
- Dividend yield
- –
Glucose Health, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2017
Profitability, TTM
- Gross margin
- 65.4%
- Operating margin
- -36.8%
- Net margin
- -96.5%
- Return on equity, FY2016
- 92.9%
Financial strength
- Current ratio
- 0.06
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 3.7%
Valuation
- P/E ratio
- –
- Price to sales
- 20.71
- Price to book
- –
- Dividend yield
- –